journal article·2010-02

Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients

M. Isabel Carretero, Manuel Pozo

Applied Clay Science· Volume 47· Issue 3-4
Publisher page

Abstract

Abstract A wide range and variety of minerals are used in the pharmaceutical industry as active ingredients. Such minerals may be administered either orally as antacids, gastrointestinal protectors, antidiarrhoeaics, osmotic oral laxatives, homeostatics, direct emetics, antianemics and mineral supplements, or parenterally as antianemics and homeostatics. They may also be used topically as antiseptics, disinfectants, dermatological protectors, anti-inflammatories, local anesthetics, keratolytic reducers and decongestive eye drops. In all cases the LADME process of the minerals is described. In the cosmetic industry minerals are used as solar protectors as well as in toothpastes, creams, powder and emulsions, bathroom salts and deodorants. The minerals in use belong to the following groups: oxides (rutile, periclase, zincite), carbonates (calcite, magnesite, hydrocincite, smithsonite), sulphates (epsomite, mirabilite, melanterite, chalcanthite, zincosite, goslarite, alum), chlorides (halite, sylvite), hydroxides (brucite, gibbsite, hydrotalcite), elements (sulphur), sulphides (greenockite), phosphates (hydroxyapatite), nitrates (niter), borates (borax) and phyllosilicates (smectite, palygorskite, sepiolite, kaolinite, talc, mica). The therapeutic activity of these minerals is controlled by their physical and physico-chemical properties as well as their chemical composition. The important properties are high sorption capacity, large specific surface area, solubility in water, reactivity toward acids, high refractive index, high heat retention capacity, opacity, low hardness, astringency, and high reflectance.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Therapeutic Uses of Natural Elements · Medical and Biological Ozone Research · Clay minerals and soil interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Bech · 1987
2. Industrial minerals in pharmaceuticals
3. Brunton, L.L., Lazo, J.S., Parker, K.L., 2005. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e. Ed. McGraw-Hill.
4. Clay minerals and their beneficial effects upon human health. A review10.1016/S0169-1317(01)00085-0 ↗
5. Carretero · 2007
6. Clay and non-clay minerals in the pharmaceutical industry. Part I. Excipients and medical applications10.1016/j.clay.2009.07.017 ↗
7. Clays and human health
8. Acid activation and bleaching capacity of bentonites from the islands of Milos and Chios, Aegean, Greece10.1016/S0169-1317(97)00017-3 ↗
9. Influence of the chemical composition and textural characteristics of palygorskite on the acid leaching of octahedral cations10.1180/claymin.1987.022.2.10 ↗
10. Del Amo y Mora · 1871
11. Layered double hydroxides and human health: an overview10.1016/j.clay.2006.06.010 ↗
12. Clays and clay minerals as drugs
13. Minerales utilizados en la industria farmaceútica
14. Effects of acid mine drainage on clay minerals suspended in the Tinto River (Río Tinto, Spain). An experimental approach10.1180/000985599546118 ↗
15. Minerals and Human Health. Benefits and Risks. Centro de Investigação«Minerais Industriais e Argilas»
16. The use of sulphur in dermatology
17. 1993 · vol. 28
18. Titanium dioxide: a different kind of sunshield
19. Characteristics of silica-coated TiO2 and its UV absorption for sunscreen cosmetic applications10.1002/sia.2313 ↗
20. Multiple renal silica calculi10.1136/bmj.1.5846.146 ↗
21. Sepiolite and palygorskite
22. Les minéraux en pharmacie
23. Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16, 16 dimethyl prostaglandin E2
24. Silica stones in the urinary bladder10.1016/S0140-6736(82)92620-4 ↗
26. Pharmaceutical and cosmetic applications of clays
27. Mineral makeover
28. Dissolution of smectites in hydrochloric acid: II. Dissolution rate as a function of crystallochemical composition10.1346/CCMN.1978.0260504 ↗
29. The efficacy of potassium salts as agents for treating dentin hypersensitivity
30. Pla Delfina · 1974
31. An overview of medicated shampoos used in dandruff treatment
32. Medicated shampoos10.1016/0738-081X(95)00119-Z ↗
33. Acid-treated montmorillonites. A study by 29Si and 27Al MAS-NMR10.1180/claymin.1994.029.1.02 ↗
34. Clay science: facts and perspectives
35. Applicazioni e utilizzazioni medico-sanitarie di materiali argillosi (naturali e modificati)
36. Acid activation of a Spanish sepiolite: physicochemical characterization, free silica content and surface area of products obtained10.1180/claymin.1994.029.3.07 ↗
37. Acid activation of a Spanish sepiolite: II. Consideration of kinetics and physicochemical modifications generated10.1180/claymin.1995.030.4.05 ↗
38. Uses of clay minerals in semisolid health care and therapeutic products10.1016/j.clay.2006.07.006 ↗
39. Clay minerals and health
40. The effect of a new toothpaste containing potassium nitrate and triclosan on gingival health, plaque formation and dentine hypersensitivity10.1111/j.1600-051X.2004.00631.x ↗